financetom
Business
financetom
/
Business
/
MTY Food Renews Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MTY Food Renews Normal Course Issuer Bid
Jun 28, 2024 5:27 AM

08:01 AM EDT, 06/28/2024 (MT Newswires) -- MTY Food Group ( MTYFF ) , a franchisor and operator of restaurants, on Friday said the Toronto Stock Exchange approved the renewal of the company's normal course issuer bid.

Under the terms of the bid, MTY can buy back up to 1.2 million common shares, or 5% of the outstanding stock, from July 3 until July 2 of next year.

Under its previous NCIB, which expires on July 2, MTY Foods bought back 498,000 common shares at a weighted average price of $48.41 each.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Lipella Pharmaceutical Shares Are Soaring Today
Why Lipella Pharmaceutical Shares Are Soaring Today
Jul 29, 2024
Lipella Pharmaceuticals Inc. ( LIPO ) shares are trading higher Monday after the company announced the enrollment of the first patients in its Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP). The Details: Lipella said the Phase 2a trial is a multi-center, dose-ranging study of LP-310, a proprietary liposomal-tacrolimus oral rinse formulation of the...
Motor racing-Sainz to move from Ferrari to Williams in 2025
Motor racing-Sainz to move from Ferrari to Williams in 2025
Jul 29, 2024
* Sainz signs two-year deal with options * Spaniard will partner Albon in 2025 * Move opens the driver market * U.S. racer Sargeant to leave (Adds details, changes dateline) LONDON, July 29 (Reuters) - Ferrari's ( RACE ) Carlos Sainz will race for Williams next season after signing a multi-year deal, the Formula One team said on Monday in...
Cognition Therapeutics Stock Tumbles On Mixed Data From Mid-Stage Alzheimer's Study
Cognition Therapeutics Stock Tumbles On Mixed Data From Mid-Stage Alzheimer's Study
Jul 29, 2024
On Monday, Cognition Therapeutics, Inc. ( CGTX ) reported that participants in the proof-of-concept Phase 2 ‘SHINE’ study who were treated with CT1812 for six months showed a consistent trend in cognitive improvement compared to placebo across all cognitive measures. In addition, there were signals of improvement in functional measures. Details of these clinical and biomarker findings were shared at the...
Micron Technology Unusual Options Activity For July 29
Micron Technology Unusual Options Activity For July 29
Jul 29, 2024
Investors with a lot of money to spend have taken a bullish stance on Micron Technology ( MU ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved